Abstract: A micro-nano sensing device for sensing a chemical, biological, or biochemical entity includes a non-conductive housing having a surface and that contains supporting logic circuitry, signaling circuitry electrically connected to the logic circuitry, and at least one electrically conductive pad positioned on the housing surface and electrically connected to the logic circuitry and to a targeting agent capable of interacting with a target.

Abstract: An apparatus that is ?m- or nm-scale in size and can include integrated circuitry logic based on sub 10 nm SIA transistor nodes, a sensing subsystem, a deciding subsystem, an effecting subsystem, and a power harvesting system is described. The sensing subsystem can identify pathogenic entities, including disease associated cells (for example, cancer cells, autoimmune cells, or pathological microbes) or viruses. The sensing subsystem can include at least one pad constructed of an electrically conductive material and linkers attached to the at least one pad. Each linker can also be attached to a targeting agent (for example, an antibody fragment) or a reference agent. Upon the binding of a targeting agent with an entity of interest, the information is transferred to the logic circuitry, which processes the binding event information and decides whether the entity is disease associated (e.g., a disease associated cell or virus) and requires delivery of therapeutic agents or other treatment.

Abstract: An apparatus that is ?m- or nm-scale in size and can include integrated circuitry logic based on sub 10 nm SIA transistor nodes, a sensing subsystem, a deciding subsystem, an effecting subsystem, and a power harvesting system is described. The sensing subsystem can identify pathogenic entities, including disease associated cells (for example, cancer cells, autoimmune cells, or pathological microbes) or viruses. The sensing subsystem can include at least one pad constructed of an electrically conductive material and linkers attached to the at least one pad. Each linker can also be attached to a targeting agent (for example, an antibody fragment) or a reference agent. Upon the binding of a targeting agent with an entity of interest, the information is transferred to the logic circuitry, which processes the binding event information and decides whether the entity is disease associated (e.g., a disease associated cell or virus) and requires delivery of therapeutic agents or other treatment.

Abstract: Edible seeds are sanitized with a composition comprising water, a biocidal agent and a solvent. The composition is applied to the seeds and the seeds are later dried without first rinsing the seeds. The application rate may be 15% by weight of the seeds or less. The solvent may be a water-miscible alcohol such as ethanol or propylene glycol. When sanitizing mucilaginous seeds, the composition comprises one or more alcohols in an amount effective to inhibit the release of mucilage. The composition is initially applied as a mist to mucilaginous seeds. The biocidal agent may be an oxidizer such as peracetic acid. A treatment system includes an atomizing sprayer and a dryer, for example a fixed bed forced-air dryer.

Abstract: Edible seeds are sanitized with a composition comprising water, a biocidal agent and a solvent. The composition is applied to the seeds and the seeds are later dried without first rinsing the seeds. The application rate may be 15% by weight of the seeds or less. The solvent may be a water-miscible alcohol such as ethanol or propylene glycol. When sanitizing mucilaginous seeds, the composition comprises one or more alcohols in an amount effective to inhibit the release of mucilage. The composition is initially applied as a mist to mucilaginous seeds. The biocidal agent may be an oxidizer such as peracetic acid. A treatment system includes an atomizing sprayer and a dryer, for example a fixed bed forced-air dryer.

Abstract: Edible seeds are sanitized with a composition comprising water, a biocidal agent and a solvent. The composition is applied to the seeds and the seeds are later dried without first rinsing the seeds. The application rate may be 15% by weight of the seeds or less. The solvent may be a water-miscible alcohol such as ethanol or propylene glycol. When sanitizing mucilaginous seeds, the composition comprises one or more alcohols in an amount effective to inhibit the release of mucilage. The composition is initially applied as a mist to mucilaginous seeds. The biocidal agent may be an oxidizer such as peracetic acid. A treatment system includes an atomizing sprayer and a dryer, for example a fixed bed forced-air dryer.

Abstract: A conduit covering system is provided including a cover having a pair of planar faces and a periphery formed therebetween. The periphery has a pair of circular portions with a pair of intermediate portions formed therebetween. The cover further includes a pair of cap side walls each having a hollow cylindrical configuration. Each cap side wall is integrally coupled to the corresponding circular portion of the periphery and extends therefrom to define a circular opening. As such, the circular openings of the cover are adapted to releasably receive ends of a pair of conduits.